Dynamic Technology Lab Private LTD Ocular Therapeutix, Inc Transaction History

Dynamic Technology Lab Private LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$2.61 - $4.41 $6,629 - $11,201	2,540 Added 19.14%	15,814 $44,000
Q3 2022 Nov 14, 2022	BUY	$4.09 - $6.5 $54,290 - $86,281	13,274 New	13,274 $55,000
Q4 2021 Feb 14, 2022	SELL	$6.16 - $12.07 $129,766 - $254,266	-21,066 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$9.7 - $14.34 $25,569 - $37,800	-2,636 Reduced 11.12%	21,066 $211,000
Q2 2021 Aug 13, 2021	BUY	$13.43 - $19.16 $38,597 - $55,065	2,874 Added 13.8%	23,702 $336,000
Q1 2021 May 14, 2021	BUY	$15.82 - $22.11 $329,498 - $460,507	20,828 New	20,828 $342,000
Q4 2020 Feb 11, 2021	SELL	$7.91 - $22.95 $316,194 - $917,403	-39,974 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$7.36 - $9.87 $294,208 - $394,543	39,974 New	39,974 $304,000
Q2 2020 Aug 14, 2020	SELL	$4.67 - $8.95 $97,883 - $187,591	-20,960 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$3.95 - $7.4 $82,792 - $155,104	20,960 New	20,960 $104,000
Q1 2019 May 13, 2019	SELL	$3.51 - $4.77 $73,980 - $100,537	-21,077 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$3.87 - $7.11 $81,567 - $149,857	21,077 New	21,077 $84,000

186

136M

284K

156K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $560M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.